The University of Manchester;National Institute On Aging;University College Cardiff Consultants Limited;VU University Medical Centre Amsterdam;UCL BUSINESS PLC;Hospital District of Helsinki and Uusima
发明人:
申请号：
EP16204118.0
公开号：
EP3202914B1
申请日:
2012.08.31
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
